These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

368 related items for PubMed ID: 30352291

  • 21. Medical and psychosocial factors and unfavourable low-density lipoprotein cholesterol control in coronary patients.
    Munkhaugen J, Sverre E, Otterstad JE, Peersen K, Gjertsen E, Perk J, Gullestad L, Moum T, Dammen T, Husebye E.
    Eur J Prev Cardiol; 2017 Jun; 24(9):981-989. PubMed ID: 28196429
    [Abstract] [Full Text] [Related]

  • 22. Statin therapy/lipid lowering therapy among Indian adults with first acute coronary event: The dyslipidemia Residual and Mixed Abnormalities IN spite of Statin therapy (REMAINS) study.
    Jaywant SV, Singh AK, Prabhu MS, Ranjan R.
    Indian Heart J; 2016 Jun; 68(5):646-654. PubMed ID: 27773403
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Lipid management in ACS: Should we go lower faster?
    Gencer B, Mach F.
    Atherosclerosis; 2018 Aug; 275():368-375. PubMed ID: 30015301
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Paradoxical impact of decreased low-density lipoprotein cholesterol level at baseline on the long-term prognosis in patients with acute coronary syndrome.
    Nakahashi T, Tada H, Sakata K, Yakuta Y, Tanaka Y, Nomura A, Gamou T, Terai H, Horita Y, Ikeda M, Namura M, Takamura M, Hayashi K, Yamagishi M, Kawashiri MA.
    Heart Vessels; 2018 Jul; 33(7):695-705. PubMed ID: 29288404
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    Lozano P, Henrikson NB, Morrison CC, Dunn J, Nguyen M, Blasi P, Whitlock EP.
    ; 2016 08. PubMed ID: 27559550
    [Abstract] [Full Text] [Related]

  • 29. [Patient's care and management of dyslipidemia at discharge after an acute coronary syndrome in the clinical practice in Spain: The SINCOPA study].
    Murga N, Ruiz E, Pascual V, en nombre de los investigadores del estudio SINCOPA.
    Clin Investig Arterioscler; 2015 08; 27(6):272-9. PubMed ID: 26100329
    [Abstract] [Full Text] [Related]

  • 30. Achievement of dual low-density lipoprotein cholesterol and high-sensitivity C-reactive protein targets more frequent with the addition of ezetimibe to simvastatin and associated with better outcomes in IMPROVE-IT.
    Bohula EA, Giugliano RP, Cannon CP, Zhou J, Murphy SA, White JA, Tershakovec AM, Blazing MA, Braunwald E.
    Circulation; 2015 Sep 29; 132(13):1224-33. PubMed ID: 26330412
    [Abstract] [Full Text] [Related]

  • 31. Rationale and design of China intensive lipid lowering with statins in acute coronary syndrome: the CHILLAS study.
    Zhao SP, Peng DQ, Yu BL, Huo Y, CHILLAS investigators.
    Am Heart J; 2009 Oct 29; 158(4):509-512.e1. PubMed ID: 19781407
    [Abstract] [Full Text] [Related]

  • 32. Evaluation of Low-density Lipoprotein Cholesterol Target Attainment Rates According to the 2016 and 2019 European Society of Cardiology/European Atherosclerosis Society Dyslipidemia Guidelines for Secondary Prevention in Patients with Acute Myocardial Infarction.
    Şimşek B, İnan D, Çınar T, Cagdas-Yumurtaş A, Ozan-Tanık V, Zeren G, İlker-Avcı İ, Yücel-Karabay C, Güngör B, Tokgozoğlu L.
    Rev Invest Clin; 2021 Nov 05; 73(3):371-378. PubMed ID: 34098569
    [Abstract] [Full Text] [Related]

  • 33. Effect of alirocumab, a monoclonal antibody to PCSK9, on long-term cardiovascular outcomes following acute coronary syndromes: rationale and design of the ODYSSEY outcomes trial.
    Schwartz GG, Bessac L, Berdan LG, Bhatt DL, Bittner V, Diaz R, Goodman SG, Hanotin C, Harrington RA, Jukema JW, Mahaffey KW, Moryusef A, Pordy R, Roe MT, Rorick T, Sasiela WJ, Shirodaria C, Szarek M, Tamby JF, Tricoci P, White H, Zeiher A, Steg PG.
    Am Heart J; 2014 Nov 05; 168(5):682-9. PubMed ID: 25440796
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Treatment of dyslipidemia in acute coronary syndrome.
    Yadav S, Sawhney JPS.
    Indian Heart J; 2024 Mar 05; 76 Suppl 1(Suppl 1):S51-S57. PubMed ID: 38307382
    [Abstract] [Full Text] [Related]

  • 37. Prescription of statins at discharge and 1-year risk of major clinical outcomes among acute coronary syndromes patients with extremely low LDL-cholesterol in clinical pathways for acute coronary syndromes studies.
    Sun Y, Xie G, Patel A, Li S, Zhao W, Yang X, Wu T, Li M, Li X, Du X, Hu R, Huo Y, Hu D, Gao RL, Wu Y.
    Clin Cardiol; 2018 Sep 05; 41(9):1192-1200. PubMed ID: 30084224
    [Abstract] [Full Text] [Related]

  • 38. Effect of Financial Incentives to Physicians, Patients, or Both on Lipid Levels: A Randomized Clinical Trial.
    Asch DA, Troxel AB, Stewart WF, Sequist TD, Jones JB, Hirsch AG, Hoffer K, Zhu J, Wang W, Hodlofski A, Frasch AB, Weiner MG, Finnerty DD, Rosenthal MB, Gangemi K, Volpp KG.
    JAMA; 2015 Nov 10; 314(18):1926-35. PubMed ID: 26547464
    [Abstract] [Full Text] [Related]

  • 39. Statins in acute coronary syndromes: do the guideline recommendations match the evidence?
    Morrissey RP, Diamond GA, Kaul S.
    J Am Coll Cardiol; 2009 Oct 06; 54(15):1425-33. PubMed ID: 19796735
    [Abstract] [Full Text] [Related]

  • 40. Persistent lipid abnormalities in statin-treated patients and predictors of LDL-cholesterol goal achievement in clinical practice in Europe and Canada.
    Gitt AK, Drexel H, Feely J, Ferrières J, Gonzalez-Juanatey JR, Thomsen KK, Leiter LA, Lundman P, da Silva PM, Pedersen T, Wood D, Jünger C, Dellea PS, Sazonov V, Chazelle F, Kastelein JJ, DYSIS Investigators.
    Eur J Prev Cardiol; 2012 Apr 06; 19(2):221-30. PubMed ID: 21450578
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.